ArticleCurrent medical imaging2026
Preoperatively Predicting Risk Stratification for GISTs ≤2 cm by Radiomics Model: A Dual-center Study
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSmall gastrointestinal stromal tumors (SGISTs, maximum diameter≤2 cm) still carry a risk of malignancy, and their preoperative evaluation remains a significant challenge. Radiomics, an emerging technique for analyzing image data, has yet to be employed to assess the risk stratification of SGISTs. To develop and validate a CT radiomics model for the preoperative prediction of risk stratification in patients with SGISTs.
methodThis study enrolled 133 patients with SGISTs, including 97 in the low-grade group and 36 in the high-grade group. Patients were randomly assigned to a training set (n = 93) and a testing set (n = 40) at a ratio of 7:3. Radiomics features were extracted from preoperative CT images, and dimensionality reduction was performed using the LR-LASSO to identify the most predictive features for constructing the radiomics model. Clinical features were evaluated using univariate and multivariate logistic regression analyses to develop a clinical model. Subsequently, the optimal radiomics and clinical features were integrated to establish a combined model. Model performance was evaluated using ROC curve analysis, and a corresponding nomogram was generated to facilitate clinical application. The Delong test was used to compare the ROC curves, with a p-value < 0.05 considered statistically significant.
resultsUnivariable clinical analysis identified maximal tumour diameter as the only significant predictor, with the clinical model achieving an AUC of 0.641 (95% CI: 0.533–0.748). Among the radiomics signatures derived from multiphase CT (non-contrast to delayed phases), the model based on portal venous phase images demonstrated the highest discriminative ability, yielding the best AUC values in both the training set (AUC = 0.848, 95% CI: 0.764–0.931) and the testing set (AUC = 0.824, 95% CI: 0.696–0.953). The combined model, which integrated radiomics features with maximum tumour diameter, demonstrated improved performance, attaining an AUC of 0.862 (95% CI: 0.743–0.975) in the training set and 0.859 (95% CI: 0.743–0.975) in the testing set. Notably, the predictive performance of both the radiomics and combined models was significantly greater than that of the clinical model (DeLong test, P < 0.05). However, no statistically significant differences were observed between the AUC values of the radiomics and combined models. Calibration curves indicated a good fit, and the DCA demonstrated that both the radiomics model and the combined model provided greater clinical benefits. DISCUSSION: The radiomics model demonstrated superior performance to the clinical model for the preoperative prediction of risk stratification in SGISTs. As a visualization tool, the nomogram of the combined model plays a critical role in optimizing early surgical resection decisions.
conclusionThe radiomics model could serve as an effective tool for non-invasive risk stratification of SGISTs, offering clear advantages over risk stratification models based solely on conventional clinical parameters. This approach could support improved preoperative clinical decisionmaking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.